Masahide Yamamoto Selected Research

Chronic Renal Insufficiency

1/2020

[Impaired hematopoiesis due to copper deficiency in a hemodialysis patient supplemented with zinc].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahide Yamamoto Research Topics

Disease

7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2024 - 02/2012
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 03/2005
5	Neoplasms (Cancer) 04/2022 - 02/2004
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2017 - 03/2005
4	Lymphoma (Lymphomas) 01/2024 - 04/2019
3	Disease Progression 01/2024 - 01/2016
3	Hemorrhage 01/2023 - 04/2006
3	Infections 01/2020 - 09/2004
3	Multiple Myeloma 12/2019 - 06/2016
3	Leukemia 01/2015 - 07/2004
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 03/2005
2	Rheumatoid Arthritis 09/2023 - 07/2017
2	Disseminated Intravascular Coagulation 01/2023 - 04/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2022 - 04/2019
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2019 - 01/2019
2	Chromosome Aberrations (Chromosome Abnormalities) 07/2017 - 03/2005
2	Philadelphia Chromosome 05/2009 - 03/2005
1	Hemorrhagic Cystitis 03/2024
1	Viremia 03/2024
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2024
1	Job Syndrome (Hyper-IgE Syndrome) 10/2023
1	Eczema 10/2023
1	Reinfection 10/2023
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2023
1	Cerebral Hemorrhage 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Back Pain (Backache) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Cholelithiasis 01/2022
1	Exanthema (Rash) 01/2022
1	Headache (Headaches) 01/2022
1	Nasopharyngitis 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Pneumoperitoneum 01/2022
1	Lobular Carcinoma 01/2022
1	Epstein-Barr Virus Infections 01/2022
1	Cytokine Release Syndrome 11/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 06/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Pancytopenia 01/2020
1	Dysgeusia (Parageusia) 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Rare Diseases (Rare Disease) 09/2019
1	Hodgkin Disease (Hodgkin's Disease) 09/2019
1	Bronchiolitis 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Pemphigus (Pemphigus Vulgaris) 01/2019
1	Bronchiolitis Obliterans 01/2019

Drug/Important Bio-Agent (IBA)

6	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 07/2004
4	Methotrexate (Mexate)FDA LinkGeneric 09/2023 - 10/2016
3	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2017
3	EnzymesIBA 04/2022 - 01/2020
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023 - 03/2015
2	Dacarbazine (DIC)FDA LinkGeneric 01/2023 - 04/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2022 - 01/2020
2	nilotinib FDA Link 01/2022 - 12/2016
2	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2021 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 10/2016
2	Rituximab (Mabthera)FDA Link 01/2017 - 02/2012
2	Phosphotransferases (Kinase)IBA 03/2005 - 07/2004
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 02/2024
1	alectinibIBA 01/2024
1	Immunoglobulin E (IgE)IBA 10/2023
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2023
1	ThrombomodulinIBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 04/2022
1	Coenzyme A (CoA)IBA 04/2022
1	palbociclibIBA 01/2022
1	Fulvestrant (Faslodex)FDA Link 01/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Methylprednisolone FDA LinkGeneric 11/2021
1	tocilizumab (atlizumab)FDA Link 11/2021
1	tisagenlecleucelIBA 11/2021
1	Ferritins (Ferritin)IBA 06/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Selenoproteins (Selenoprotein)IBA 01/2021
1	polaprezinc (Z 103)IBA 01/2020
1	CopperIBA 01/2020
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	ZincIBA 01/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2019
1	Acetates (Acetic Acid Esters)FDA Link 04/2019
1	Desmoglein 1IBA 01/2019
1	AntibodiesIBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019

Therapy/Procedure

23	Therapeutics 01/2024 - 09/2004
6	Hematopoietic Stem Cell Transplantation 03/2024 - 09/2008
3	Stem Cell Transplantation 01/2024 - 01/2019
2	Drug Therapy (Chemotherapy) 07/2017 - 05/2009
1	Induction Chemotherapy 01/2023
1	Intravenous Anesthesia 01/2022
1	Laparoscopic Cholecystectomy 01/2022
1	Renal Dialysis (Hemodialysis) 01/2020
1	Salvage Therapy 12/2019